Resonance Health (ASX:RHT) Change In Receivables : A$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

What is Resonance Health Change In Receivables?

Resonance Health's change in receivables for the quarter that ended in Dec. 2023 was A$0.00 Mil. It means Resonance Health's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

Resonance Health's change in receivables for the fiscal year that ended in Jun. 2023 was A$0.00 Mil. It means Resonance Health's Accounts Receivable stayed the same from Jun. 2022 to Jun. 2023 .

Resonance Health's Accounts Receivable for the quarter that ended in Dec. 2023 was A$1.26 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Resonance Health's Days Sales Outstanding for the six months ended in Dec. 2023 was 70.57.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Resonance Health's liquidation value for the six months ended in Dec. 2023 was A$5.76 Mil.

Resonance Health Change In Receivables Historical Data

The historical data trend for Resonance Health's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resonance Health Change In Receivables Chart

Resonance Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Receivables

Get a 7-Day Free Trial

Resonance Health Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Resonance Health Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Resonance Health (ASX:RHT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Resonance Health's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.263	/	3.266	*	91
=	70.57

2. In Ben Graham's calculation of liquidation value, Resonance Health's accounts receivable are only considered to be worth 75% of book value:

Resonance Health's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	5.898	-	1.083	+	0.75 * 1.263	+	0.5 * 0
=	5.76

Resonance Health Change In Receivables Related Terms

Thank you for viewing the detailed overview of Resonance Health's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Resonance Health (ASX:RHT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Resonance Health Ltd (ASX:RHT) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

141 Burswood Road, Level 1, Burswood, WA, AUS, 6100

Website

https://www.resonancehealth.com

Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, and HepaFat-Scan. The company's operating segment includes Services; Research and Development and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of its revenue from North America and Europe-Middle-East-Africa (EMEA) and also has a presence in Asia/Pacific.

Resonance Health (ASX:RHT) Headlines

No Headlines